RCT: Ranolazine shows benefit for persistent angina in patients with type 2 diabetes
Source: Journal of the American College of Cardiology Area: News According to data presented at the American Society of Cardiology annual meeting, and published early online in the Journal of the American College of Cardiology, ranolazine reduced episodes of chest pain in patients with diabetes.   Researchers examined the efficacy of ranolazine versus placebo on weekly angina frequency in patients with type 2 diabetes, coronary artery disease (CAD), and chronic stable angina who remain symptomatic despite treatment with up to 2 anti-anginal agents.   The trial, Type 2 Diabetes Evaluation of Ranolazine i...
Source: NeLM - Cardiovascular Medicine - March 12, 2013 Category: Cardiology Source Type: news